NC-1 | Interleukin Related interleukin-related.com

Product Name :
NC-1

Search keywords :
NC1

drugId :
null

Target Vo:
Tyrosine-protein kinase BTK

Target Vo Short Name :
BTK

Moa_Name:
Tyrosine-protein kinase BTK modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Weizmann Institute Of Science

Active Company_Name :
Weizmann Institute Of Science

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bermekimab Interleukin Related
Cyclin E1 Rabbit pAb Protocol
Myc-tag Antibody: Myc-tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Myc-tag. It can be used for WB,ELISA,IP assays with Myc-tag, in the background of .

Author: Interleukin Related

Related Posts